The purpose of this study is to test whether it is safe to give phenformin with the standard
drug combination of dabrafenib + trametinib. The combination of dabrafenib plus trametinib is
a standard treatment for patients with metastatic melanoma whose melanoma has a mutation in a
gene called BRAF.